BioSpace News Archive

Roman Fischer of Oxford University demonstrates high-throughput 4D proteomics on non-depleted, untreated plasma identifying >350 protein groups with short 10-20 minute methods, enabling high throughput, robust biomarker discovery OmicEra Diagnostics reports running 720 undepleted serum samples from 31 COVID-19 patients over just 12 days on a single timsTOF Pro system at a rate of 60 samples/day

Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of its new Air-Dryable Direct DNA qPCR Blood Mix, which is specifically designed for the manufacturing of room-temperature stable molecular diagnostic assays direct from whole blood, serum or plasma.

Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, will be participating in the following virtual investor conferences.

In an era when consumers are demanding more from producers for better, faster, and stronger products, the biotechnology industry is not exempt.

This new EMA designation provides NervGen with multiple incentives, including improved access to scientific advice, fee reductions, and 10 years of protection from market competition in Europe from similar medicines with similar indications following the date that the drug candidate receives marketing authorization (called market exclusivity).

Iconic Eyecare is proud to announce the grand opening of its office in Surrey, British Columbia. The dedicated staff is ready to help with quality eye care at their full-service optometry practice.

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported that it raised $11 million in new capital from sales of its holdings of marketable securities, including shares of OncoCyte Corporation (Nasdaq: OCX)

Business leaders and community organizations have joined forces to support R.E.S.T., “Reopening Effectively and Safely Together”, a multi-state mission and initiative created and designed to address the tough challenges ahead as we look forward to the post-COVID-19 world.

Webinar to discuss results on March 10, 2021 at 4:30 p.m. E.T

The Clinton Health Access Initiative and the American Cancer Society announced the expansion of the Cancer Access Partnership to further increase access to lifesaving cancer treatments in low- and middle-income countries in Africa and Asia.